Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | ESRRB | O95718 | 1/20 | 0.44 |
| ▸ | ESRRG | P62508 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12081800 | 0.91 | HPGD (0.53) | HPGDL3MBTL1KDM4EGLALMNA | |
| SCHEMBL19102882 | 0.90 | HPGD (0.59) | HPGDL3MBTL1KDM4EGLARAB9A | |
| SCHEMBL12082078 | 0.89 | HPGD (0.58) | HPGDL3MBTL1KDM4EGLARAB9A | |
| SCHEMBL14679435 | 0.86 | HPGD (0.68) | HPGDL3MBTL1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL14864126 | 0.84 | HPGD (0.49) | HPGDL3MBTL1KDM4EGLALMNA | |
| SCHEMBL14198712 | 0.84 | TRPV1 (0.56) | HPGDL3MBTL1KDM4EGLARAB9A | |
| SCHEMBL4949674 | 0.82 | CA12 (0.60) | RAB9ALMNASMN1; SMN2GAA | |
| Hydrochloric Acid SCHEMBL327795 | 0.82 | TRPV1 (0.55) | HPGDL3MBTL1KDM4EGLARAB9A | |
| SCHEMBL4528693 | 0.81 | HPGD (0.66) | HPGDL3MBTL1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL18232424 | 0.81 | PDK2 (0.65) | HPGDL3MBTL1KDM4EGLARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150368261-A1 | CONJUGATES AND SMALL MOLECULES WHICH INTERACT WITH THE CD16A RECEPTOR | BIOINTEGRATOR LTD LIABILITY COMPANY (RU) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368261-A1 | CONJUGATES AND SMALL MOLECULES WHICH INTERACT WITH THE CD16A RECEPTOR | FCGR1A, FCGR2A, FCGR3B | HPGD 3206/4885L3MBTL1 2830/4885KDM4E 3825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.